InSBGrid Community NewsbySBGridThe science behind fight or flightSBGrid member Xin-Yun Huang identifies distinct binding mechanisms between the stress hormone epinephrine and adrenergic receptorsSep 27
Heejong KimHow to create a composite map in ChimeraLet’s say you did local refinement to get higher resolution maps for certain areas and you want to combine them into a single map. In many…May 1
InSBGrid Community NewsbySBGridHow do bacteria see light?SBGrid Member Emina Stojković describes how photoelectric energy is converted into mechanical energy in a bacterial phytochrome.Aug 28Aug 28
InAmplitude VCbyAmplitude VenturesGandeeva Therapeutics — unlocking the power of cryo-EMGandeeva Therapeutics $40M Series A Financing — why we’re excitedJan 31, 2022Jan 31, 2022
InSBGrid Community NewsbySBGridUnderstanding how positive allosteric modulators regulate metabotropic glutamate receptorsSBGrid member Joshua Levitz and colleagues examine how PAMs improve the function and internalization of mGluRs.Aug 27Aug 27
InSBGrid Community NewsbySBGridThe science behind fight or flightSBGrid member Xin-Yun Huang identifies distinct binding mechanisms between the stress hormone epinephrine and adrenergic receptorsSep 27
Heejong KimHow to create a composite map in ChimeraLet’s say you did local refinement to get higher resolution maps for certain areas and you want to combine them into a single map. In many…May 1
InSBGrid Community NewsbySBGridHow do bacteria see light?SBGrid Member Emina Stojković describes how photoelectric energy is converted into mechanical energy in a bacterial phytochrome.Aug 28
InAmplitude VCbyAmplitude VenturesGandeeva Therapeutics — unlocking the power of cryo-EMGandeeva Therapeutics $40M Series A Financing — why we’re excitedJan 31, 2022
InSBGrid Community NewsbySBGridUnderstanding how positive allosteric modulators regulate metabotropic glutamate receptorsSBGrid member Joshua Levitz and colleagues examine how PAMs improve the function and internalization of mGluRs.Aug 27
InSBGrid Community NewsbySBGridFuture directions in drug development against antibiotic resistant bacteriaSBGrid member Daniel Kahne investigates how Zosurabalpin, along with two other chemical compounds, interact with LptB₂FGC.Jul 30
InSBGrid Community NewsbySBGridMethaqualone research offers new insights for designing safer GABA(A) receptor drug targetsSBGrid Member Ryan Hibbs uses cryo-electron microscopy to reveal the exact binding sites and structural changes in the GABA(A) receptor…Jun 28
InSBGrid Community NewsbySBGridNew insights into how antibodies regulate GPCR signalingSBGrid member Andew Kruse from Harvard Medical School, explores the use of engineered antibodies, called nanobodies, to enhance targeting…May 30
